Search This Blog

Monday, July 7, 2025

WuXi AppTec Updates on Q2 Share Repurchase/Acquisition Activities

 WuXi AppTec Co., Ltd. (Stock codes: 603259.SH/2359.HK), a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, recently provided updates to investors on the status of its A-share repurchase and H-share acquisition activities in Q2 2025.

The Company repurchased and cancelled RMB1.0 billion worth of A-share to enhance shareholder value, and instructed the trustee (the "Scheme Trustee") of its 2025 H Share Award and Trust Scheme to acquire HKD2.5 billion worth of H-share for the purpose of attracting and retaining highly talented employees.

Here is a full update on both programs:  

Update on A-Share Repurchase and Cancellation:

  • On April 8, 2025, the Company's Board of Directors approved an RMB1.0 billion A-share repurchase and cancellation program. It took this action to uphold the Company's value and protect the interests of shareholders.
  • From April 18, 2025 to June 20, 2025, WuXi AppTec spent RMB1.0 billion (exclusive of transaction fees) to buy an aggregate of 15,775,377 A Shares (representing approximately 0.55% of the Company's total issued share capital as of June 23, 2025) at an average price of RMB63.39 per share.
  • On June 24, 2025, WuXi AppTec completed cancellation of all A Shares repurchased under this program.
  • For more information, please refer to the Company's relevant announcement:

Update on H-Share Acquisition:

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.